Joint venture between Insception Lifebank, the Lunenfeld-Tanenbaum Research Institute and Ontario Centres of Excellence aims to develop iPSCs from cord blood and cord tissue.
Insception Lifebank Cord Blood Program (“Insception”) is excited to announce its collaboration with Dr. Ian Rogers, from the The Lunenfeld-Tanenbaum Research Institute, part of Sinai Health System, to develop clinical grade induced pluripotent stem cells (iPSCs) from umbilical cord blood and tissue. This collaboration has been awarded funding through the Ontario Centres of Excellence (“OCE”) Voucher for Innovation and Productivity II program which helps established Ontario-based companies develop, implement and commercialize technical innovations by supporting partnerships with academia.
iPSCs hold great promise in the field of regenerative medicine and are considered the gateway to personalized medicine. iPSCs can be propagated indefinitely and can give rise to every cell type in the body (including neurons, heart, pancreatic and liver cells). This renders iPSCs into a single source of cells that could be used in regenerative medicine to replace cells lost to, or damaged by, disease.
The aim of this joint venture with Dr. Rogers is to develop robust technology to produce iPSCs from cord blood and cord tissue, along with other cell sources, and to explore the feasibility of establishing an iPSC banking program at Insception. If feasible, this program would allow individuals, and families, to bank a secured source of well characterized iPSCs so they could readily take advantage of new cellular therapies being developed world-wide.
Insception, Sinai Health System and OCE are committed to setting the standard for the highest quality in research and innovation. This project will continue to push the future of medicine, contributing to the future health and well-being of Canadians.
Insception Lifebank Cord Blood Program is Canada’s largest and most experienced cord blood bank. It is accredited by FACT, AABB and Health Canada. The Company provides cord blood and cord tissue collection, processing, cryopreservation storage and stem cell product development. It operates across Canada with a purpose built state of the art facility in Mississauga, On.
About The Lunenfeld-Tanenbaum Research Institute, part of Sinai Health System
The Lunenfeld-Tanenbaum Research Institute, located at Mount Sinai Hospital, is a leading biomedical research centre, ranking amongst the top biomedical research institutes in the world. Established in 1985, the institute is profoundly advancing understanding of human biology in health and disease. Many of the breakthroughs that began as fundamental research have resulted in new and better ways to prevent, diagnose and treat prevalent conditions. The institute is affiliated with the University of Toronto and is focused on women’s and infants’ health, cancer biology, stem cell biology, neurobiology, diabetes, arthritis, health systems research, population health services and solutions, and systems biology. www.lunenfeld.ca.
Ontario Centres of Excellence (OCE) drives the commercialization of cutting-edge research to build the economy of tomorrow and secure Ontario’s global competitiveness. OCE fosters the training and development of the next generation of innovators and entrepreneurs and is a key partner with Ontario’s industry, universities, colleges, research hospitals, domestic and foreign investors, and government ministries. A champion of leading-edge technologies, best practices, innovation, entrepreneurship and research, OCE invests in such areas as advanced health, information and communications technology, digital media, advanced materials and manufacturing, agri-food, aerospace, transportation, energy, and the environment including water and mining. OCE is a key partner in delivering Ontario’s Innovation Agenda as a member of the province’s Ontario Network of Entrepreneurs (ONE), which helps Ontario-based entrepreneurs and industry rapidly grow their company and create jobs. Learn more at www.onebusiness.ca